Related Experiment Video
Updated: Jul 14, 2026
09:52
Generation of High Quality Chromatin Immunoprecipitation DNA Template for High-throughput Sequencing (ChIP-seq)
Published on: April 19, 2013
The new type 2 diabetes gene TCF7L2
1Diabetes Unit and Center for Human Genetic Research, Massachusetts General Hospital, Boston, MA 02114, USA. jcflorez@partners.org
Current Opinion in Clinical Nutrition and Metabolic Care
|June 15, 2007
Summary
Common variants in the transcription factor 7-like 2 (TCF7L2) gene are strongly linked to type 2 diabetes. This discovery offers new insights into diabetes pathophysiology and risk prediction.
Area of Science:
- Genetics
- Endocrinology
- Molecular Biology
Background:
- Type 2 diabetes is a complex metabolic disorder with a significant genetic component.
- The transcription factor 7-like 2 (TCF7L2) gene has emerged as a key player in diabetes susceptibility.
Purpose of the Study:
- To review the association between TCF7L2 gene variants and type 2 diabetes.
- To explore the implications of this association for understanding glycemic pathophysiology and diabetes risk.
Main Methods:
- Genome-wide association studies (GWAS) and replication studies.
- Fine-mapping of TCF7L2 association signals.
- Analysis of TCF7L2 variant effects on metabolic parameters in human populations.
Main Results:
- Consistent replication of TCF7L2 variants' association with type 2 diabetes across diverse populations.
- Identification of specific TCF7L2 variants contributing to diabetes risk.
- Demonstration of TCF7L2's impact on human metabolic parameters.
Conclusions:
- TCF7L2 is a validated diabetes gene, highlighting the success of genetic association studies in identifying novel disease-related genes.
- Findings from TCF7L2 research can inform diabetes risk prediction models and therapeutic strategies.
- Further identification of genes like TCF7L2 is crucial for elucidating the genetic architecture of type 2 diabetes.
Related Concept Videos
01:26Type II Diabetes I: Introduction
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:12Type I Diabetes I: Introduction
Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:22Diabetes Mellitus: Overview and Type I Subtype
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...